HepQuant Named Rising Star of the Year Finalist by Colorado BioScience Association

HepQuant, a member of Fitzsimons Innovation Community, has been named a Rising Star of the Year finalist for the Colorado BioScience Association’s 23rd Annual Awards Celebration, recognizing emerging life sciences companies advancing innovation and improving patient care. HepQuant joins fellow finalists Think Bioscience and VitriVax in the category, with winners to be announced at the November 12 celebration in Denver.

The recognition follows a milestone year for HepQuant, including U.S. Food and Drug Administration premarket approval of its SHUNT Liver Diagnostic Test in June 2026 and accreditation from the College of American Pathologists. The company is advancing blood-based diagnostic technologies that provide clinicians with greater insight into liver function, supporting more informed treatment decisions and the development of new therapies. Its selection highlights the continued growth and scientific achievements of companies within Fitzsimons Innovation Community.

Read the full announcement: Colorado BioScience Association Announces Finalists, Honorees, and Speakers for 23rd Annual Awards Celebration

Source: Colorado BioScience Association